Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado Yale - New Haven Hospital - Yale Cancer Center, New Haven, Connecticut Florida Cancer Specialists, Sarasota, Florida Massachusetts General Hospital, Boston, Massachusetts START Midwest, LLC, Grand Rapids, Michigan